Active Substance: Valganciclovir (as HCl).
Overview
Welcome to Dwaey, specifically on GANCIL 450 page.
This medicine contains an important and useful components, as it consists of
Valganciclovir (as HCl)is available in the market in concentration
Valganciclovir
Patient w/ pre-existing haematological cytopenia, history of drug-related haematological cytopenia. Renal impairment. Pregnancy. Lactation: not known if distributed in breast milk; do not nurse
Cytomegalovirus infections
Hypersensitivity. Haemodialysis patients (CrCl <10 mL/min). Lactation. Should not be administered if the absolute neutrophil count is <500 cells/?L, platelet count is <25,000/?L, or Hb is <8 g/dL.
>10% Abdominal pain (15%),Anemia (8-26%),Diarrhea (16-41%),Fever (31%),Granulocytopenia (11-27%),Headache (9-22%),Insomnia (16%),Nausea (8-30%),Retinal detachment (15%),Vomiting (21%) 1-10% Peripheral neuropathy (9%),Paresthesia (8%),Seizures (<5%),Psychosis, hallucinations (<5%),Confusion (<5%),Agitation (<5%),Thrombocytopenia (8%),Pancytopenia (<5%),Bone marrow depression (<5%),Aplastic anemia (<5%),Bleeding, potentially life-threatening due to thrombocytopenia (<5%),Decr renal function (<5%),,Local & systemic infections, incl sepsis (<5%),Allergic reaction (<5%)
3
Valganciclovir is an L-valyl ester (prodrug) of ganciclovir that exists as a mixture of 2 diastereomers. After oral admin, both diastereomers are rapidly converted to ganciclovir by intestinal and hepatic esterases. Ganciclovir is a synthetic analogue of 2'-deoxyguanosine, which inhibits replication of human cytomegalovirus (CMV) in cell culture and in vivo.
Convulsions may occur if taken concomitantly w/ imipenem-cilastatin. Increased exposure w/ probenecid. Increased risk of neutropenia and anaemia w/ zidovudine. May increase plasma concentrations of didanosine. Increased risk of neutropenia and leucopenia w/ mycophenolate mofetil. Increased risk of peripheral neuropathy w/ zalcitabine. Enhanced toxicity w/ other drugs that inhibit replication of rapidly dividing cells (e.g. dapsone, vincristine, vinblastine, amphotericin B, trimethoprim/sulfa combinations, nucleoside analogues, hydroxyurea), cidofovir, foscamet.
Information not available